Facts and fallacies about vaccination by the Dutch Influenza Foundation
An independent information document for nurses
Australian vaccination warning as flu lingers into summer 2023/24
Winter may be long gone and summer just around the corner, but the flu season is dragging on with all states continuing to record cases.
RSV IMMUNISATION FOR INFANTS IN EUROPE: ARE OUR HEALTH SYSTEMS READY?
EHMA publishes a paper based on expert insight from across Europe, exploring the challenges and opportunities of implementing RSV immunisation programmes in different country contexts.
Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions
Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired pneumonia as the major disease-related burden.
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
|
ESWI Airborne: Immunisation & Treatment
Immunisation & Treatment - Societal benefits of immunising children
Is there a difference between recommending flu, RSV and COVID-19 vaccinations in children? What is meant by preventing secondary diseases and other societal wider benefits? ...
|
ESWI Airborne: Immunisation & Treatment
Immunisation & Treatment - New approaches to influenza prevention and treatment - lessons learnt from COVID- 19
Flu is the forgotten killer. What new vistas of vaccinology opened up after the COVID-19 pandemic? In what ways can flu treatments change as a consequence of lessons learned?
|
ESWI Airborne: Immunisation & Treatment
Immunisation & Treatment - Travel preparedness and vaccinations
How has the world of travel medicine evolved? What multiple roles do vaccinations have? What impact did the COVID-19 pandemic have on travel behaviour? Why is it so important to keep up to date on the current epidemiological situation?
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
Novel immunisation methods against respiratory syncytial virus (RSV) are emerging, but knowledge of risk factors for severe RSV disease is insufficient for optimal targeting of interventions against them.
Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism
Research shows that the procoagulant state of PBMC could aid in the early detection of PE in COVID-19 ICU patients. When combined with the end-tidal to ETCO2 – PaCO2 gradient, these tests could improve the early detection of PE in the ICU.
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model
Novel immunisation methods against respiratory syncytial virus (RSV) are emerging, but knowledge of risk factors for severe RSV disease is insufficient for optimal targeting of interventions against them.
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants
Infants younger than 6 months are at risk of severe SARS-CoV-2 infection.
